Skip to main content
. Author manuscript; available in PMC: 2014 Apr 30.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Sep 8;(9):CD007575. doi: 10.1002/14651858.CD007575.pub2
Study Reason for exclusion
Baum 1963 Quasi-randomised, alternate allocation of patients to groups
Bayreuther 1994 Crossover design.
Can Gurkan 2008 Planned as a randomised study, but not carried out as planned (patients on each day placed in same group)
Cartwright 1951 Crossover design.
Conklin 1958 Not randomised, patients “arbitrarily allocated” to groups.
De Aloysio 1992 Crossover design.
Diggory 1962 Quasi-randomised “each patient in sequence was allocated”; control group reallocated if not improving
Dundee 1988 Not an RCT; women allocated to groups by day of the week; non-responders replaced in treatment group
Evans 1993 Crossover design.
Ferruti 1982 This is a study of hypocorticalism in pregnancy.
Fitzgerald 1955 Not an RCT; alternate allocation of patients.
Heazell 2006 Severe symptoms, in-patient; hyperemesis gravidarum implied (severe symptoms plus ketonuria)
Higgins 2009 Hyperemesis gravidarum (day care versus in-patient management; trial registry record only, no data)
Hyde 1989 Crossover design.
Kadan 2009 Hyperemesis gravidarum as specified condition of participants (RCT, with crossover if first drug allocated not effective: thiamine 100mg IV or promethazine 25mg IV; started February 2009, trial registry record only, ongoing at May 2010)
King 1955 Type of crossover design.
Koren 2006 Pre-emptive treatment; not treating symptoms.
Lask 1953 Not an RCT.
Luz 1987 No data available; this is a communication of a planned trial - a search identified no further publications from this study
Steele 2001 Quasi-experimental design posttest-only and post-test repeated measure
Wheatley 1977 Crossover design.
Winters 1961 Quasi randomised trial - “test material and placebo were strictly alternated”

IV: intravenous

RCT: randomised controlled trial